For research use only. Not for therapeutic Use.
Enrofloxacin Monohydrochloride（Cat No.:I017447）is a broad-spectrum fluoroquinolone antibiotic used in veterinary medicine to treat bacterial infections in animals. As the monohydrochloride salt form, it enhances solubility and bioavailability. It is primarily effective against Gram-negative and Gram-positive bacteria by inhibiting bacterial DNA gyrase, which is essential for DNA replication and transcription. Enrofloxacin Monohydrochloride is commonly utilized in the treatment of respiratory, gastrointestinal, and urinary tract infections in animals. It also has applications in aquaculture for managing fish diseases, making it a versatile agent in animal health and veterinary research.
| Catalog Number | I017447 |
| CAS Number | 93106-59-3 |
| Molecular Formula | C₁₉H₂₃ClFN₃O₃ |
| Purity | ≥95% |
| Target | Metabolic Enzyme/Protease |
| IUPAC Name | 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid;hydrochloride |
| InChI | InChI=1S/C19H22FN3O3.ClH/c1-2-21-5-7-22(8-6-21)17-10-16-13(9-15(17)20)18(24)14(19(25)26)11-23(16)12-3-4-12;/h9-12H,2-8H2,1H3,(H,25,26);1H |
| InChIKey | PZJWYUDBXNNVLZ-UHFFFAOYSA-N |
| SMILES | CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl |
| Reference | [1]. Sulyok KM, et al.Antibiotic susceptibility profiles of Mycoplasma bovis strains isolated from cattle in Hungary, Central Europe. BMC Vet Res. 2014 Oct 25;10:256.<br>[2]. Hetze S, et al. Superiority of preventive antibiotic treatment compared with standard treatment of poststroke pneumonia in experimental stroke: a bed to bench approach. J Cereb Blood Flow Metab. 2013 Jun;33(6):846-54. |
